Vascular Anomalies Review of the Head and Neck for Physicians in Training
DOI:
https://doi.org/10.5195/ijms.2024.2665Keywords:
vascular anomalies, vascular tumors, vascular malformations, infantile hemangioma, PHACES syndrome, congenital hemangioma, lymphatic malformation, capillary malformation, Sturge Weber syndrome, venous malformation, ateriovenous malformation, propranolol, sclerotherapy, glue embolizationAbstract
A basic understanding of vascular anomalies will aid physicians-in-training as they seek to properly diagnose and determine interventions for these patient presentations. The aim of this review is to create a resource for physicians in training that encompasses the most important clinical aspects of vascular anomalies. Vascular anomalies of the head and neck are divided into two categories: vascular tumors and vascular malformations. This review will first describe vascular tumors followed by vascular malformations. This review discusses major pathology found in both categories of vascular anomaly. Vascular anomalies are frequently found in pediatric populations and can persist into adulthood, making it important for trainees to identify them on physical exam. This developing field seeks to improve form, function, and quality of life for patients with vascular anomalies and often requires a multidisciplinary approach (i.e., otolaryngology, dermatology, genetics, plastic surgery, interventional radiology). Various medical and surgical treatment options are available. A basic knowledge of these anomalies will allow for accurate, early diagnosis and appropriate intervention which can ultimately improve patient outcomes.
Search Strategy and Selection Criteria: The MEDLINE/PubMed database was searched for primary research and reviews discussing various vascular anomalies which include infantile hemangioma, congenital hemangioma, pyogenic granuloma, tufted angioma, kaposiform hemangioendothelioma, capillary malformations, lymphatic malformations, venous malformations, and arteriovenous malformations. This search was conducted from 7/5/2023 to 3/21/2024.
Metrics
References
Munden A, Butschek R, Tom WL, Marshal JS, Poeltler DM, Krohne SE, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170(4):907-913.
Perkins JA, Balakrishnan K. Evidence-Based Management of Head and Neck Vascular Anomalies. (Springer International Publishing, ed.).; 2018.
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136(1):e203-14.
Mansfield SA, Williams RF, Iacobas I. Vascular tumors. Semin Pediatr Surg. 2020;29(5):150975.
Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341(3):173-181. 10.1056/NEJM199907153410307
Leung AKC, Lam JM, Leong KF, Hon KL. Infantile Hemangioma: An Updated Review. Curr Pediatr Rev. 2021;17(1):55-69.
DeHart A, Richter G. Hemangioma: Recent Advances. F1000Res. 2019;8.
Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Birth Defects Res. 2017;109(11):809-815.
North PE, Waner M, Mizeracki A, Mihm MC. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31(1):11-22.
Barnés CM, Huang S, Kaipainen A, Sanoudou D, Chen E, Eichler, G, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A. 2005;102(52):19097-19102.
Strub GM, Kirsh AL, Whipple ME, Kuo W, Keller R, Kapur R, et al. Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma. JCI Insight. 2016;1(14):e88856.
Huoh KC, Rosbe KW. Infantile hemangiomas of the head and neck. Pediatr Clin North Am. 2013;60(4):937-949.
Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138(12):1567-1576.
Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics. 2006;117(3):698-703.
Darrow DH, Greene AK, Mancini AJ, Nopper AJ, SECTION ON DERMATOLOGY SOOANS and SOPS. Diagnosis and Management of Infantile Hemangioma. Pediatrics. 2015;136(4):e1060-104.
Esposito F, Ferrara D, Di Serafino M, Severino M, Nosari R, Galdieri M, et al. Classification and ultrasound findings of vascular anomalies in pediatric age: the essential. J Ultrasound. 2019;22(1):13-25.
Moukaddam H, Pollak J, Haims AH. MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol. 2009;38(6):535-547.
Haggstrom AN, Drolet BA, Baselga E, Chamlin S, Garzon M, Horii K, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006;118(3):882-887.
Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman N, Chiu R, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128-140.
Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Atti MCD, et al. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr. 2015;174(7):855-865.
Barrio VR, Drolet BA. Treatment of hemangiomas of infancy. Dermatol Ther. 2005;18(2):151-159.
Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996;132(3):307-311.
Hess CP, Fullerton HJ, Metry DW, Drolet B, Siegel D, Auguste KI, et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol. 2010;31(10):1980-1986.
Girard C, Bigorre M, Guillot B, Bessis D. PELVIS Syndrome. Arch Dermatol. 2006;142(7):884-888.
Stockman A, Boralevi F, Taïeb A, Léauté-Labrèze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology. 2007;214(1):40-45.
Glick ZR, Frieden IJ, Garzon MC, Mully TW, Drolet BA. Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature. J Am Acad Dermatol. 2012;67(5):898-903.
Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28(3):267-275.
Berenguer B, Mulliken JB, Enjolras O, Bellini C, Burrows PE, Sundel RP, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003;6(6):495-510.
Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol. 2004;50(6):875-882.
Patrice SJ, Wiss K, Mulliken JB. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol. 1991;8(4):267-276.
Harris MN, Desai R, Chuang TY, Hood AF, Mirowski GW. Lobular capillary hemangiomas: An epidemiologic report, with emphasis on cutaneous lesions. J Am Acad Dermatol. 2000;42(6):1012-1016.
Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol. 2001;45(1):1-19; quiz 19-22.
Eshkevari S, Kabir S, Alizadeh N, Nickhaha N. Curettage and punch excision of the vascular base: an effective method for treatment of pyogenic granuloma with excellent results. Iran J Dermatol. 2014;17(69):91-5.
Croteau SE, Gupta D. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma. Semin Cutan Med Surg. 2016;35(3):147-152.
Kelly M. Kasabach-Merritt phenomenon. Pediatr Clin North Am. 2010;57(5):1085-1089.
McDaniel CG, Adams DM, Steele KE, Hammill AM, Merrow AC, Crane JL, et al. Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. Pediatr Blood Cancer. 2023;70(4):e30219.
Carqueja IM, Sousa J, Mansilha A. Vascular malformations: classification, diagnosis and treatment. Int Angiol. 2018;37(2):127-142.
Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161(2):240-245.
Dutkiewicz AS, Ezzedine K, Mazereeuw-Hautier J, Lacour JP, Barbarot S, Vabres P, et al. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain. J Am Acad Dermatol. 2015;72(3):473-480.
Roach ES. Neurocutaneous syndromes. Pediatr Clin North Am. 1992;39(4):591-620.
Adams ME, Aylett SE, Squier W, Chong W. A spectrum of unusual neuroimaging findings in patients with suspected Sturge-Weber syndrome. AJNR Am J Neuroradiol. 2009;30(2):276-281.
Gonzalez CD, Mcdonald J, Stevenson DA, Whitehead KJ, Petersen MG, Presson AP, et al. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia. Laryngoscope. 2018;128(7):1714-1719.
Faurschou A, Olesen AB, Leonardi-Bee J, Haedersdal M. Lasers or light sources for treating port-wine stains. Cochrane Database Syst Rev. 2011;(11):CD007152.
Marqués L, Núñez-Córdoba JM, Aguado L, Pretel M, Boixeda P, Nagore E, et al. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial. J Am Acad Dermatol. 2015;72(1):151-8.e1.
Longstreet B, Balakrishnan K, Saltzman B, Perkins JA, Dighe M. Prognostic value of a simplified anatomically based nomenclature for fetal nuchal lymphatic anomalies. Otolaryngol Head Neck Surg. 2015;152(2):342-347.
Cash H, Bly R, Masco V, Shwayhat EU, Lutz DR, Van Tine LP, et al. Prenatal Imaging Findings Predict Obstructive Fetal Airways Requiring EXIT. Laryngoscope. 2021;131(4):E1357-E1362.
Dighe MK, Peterson SE, Dubinsky TJ, Perkins J, Cheng E. EXIT procedure: technique and indications with prenatal imaging parameters for assessment of airway patency. Radiographics. 2011;31(2):511-526.
de Serres LM, Sie KC, Richardson MA. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg. 1995;121(5):577-582.
Bonilla-Velez J, Whitlock KB, Ganti S, Theeuwen HA, Manning S, Bly R, et al. Active Observation as an Alternative to Invasive Treatments for Pediatric Head and Neck Lymphatic Malformations. Laryngoscope. 2021;131(6):1392-1397.
Luks VL, Kamitaki N, Vivero MP, Wang K, Ameen N, Bader A, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166(4):1048-54.e1-5.
Zenner K, Cheng CV, Jensen DM, Timms A, Shivaram G, Bly R, et al. Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations. JCI Insight. 2019;4(21).
Keppler-Noreuil KM, Rios JJ, Parker VER, Semple RK, Lindhurst MJ, Sapp JC, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287-295.
Kurek KC, Luks VL, Ayturk UM, Alomari AI, Fishman SJ, Spencer SA, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet. 2012;90(6):1108-1115.
Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA Otolaryngol Head Neck Surg. 2014;140(1):41-45.
Bonilla-Velez J, Whitlock KB, Ganti S, Theeuwen HA, Manning SC, Bly RA, et al. Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformations. Int J Pediatr Otorhinolaryngol. 2021;151:110869.
Fraulin FO, Flannigan RK, Sharma VK, McPhalen DF, Harrop RA. The epidemiological profile of the Vascular Birthmark Clinic at the Alberta Children’s Hospital. Can J Plast Surg. 2012;20(2):67-70.
Hung JWS, Leung MWY, Liu CSW, Choi CHT, Wong KW, Kwan HN. Venous Malformation and Localized Intravascular Coagulopathy in Children. Eur J Pediatr Surg. 2017;27(2):181-184.
Koo KSH, Dowd CF, Mathes EF, Sidhu K, Fuchs HE, Peters SM, et al. MRI phenotypes of localized intravascular coagulopathy in venous malformations. Pediatr Radiol. 2015;45(11):1690-1695.
Dompmartin A, Ballieux F, Thibon P, Veyrac C, Verlaine M, Lacour JP, et al. Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol. 2009;145(11):1239-1244.
Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations. Mol Syndromol. 2013;4(4):179-183.
Limaye N, Wouters V, Uebelhoer M, Pappas P, Mahoney W, Van Agtmael T, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41(1):118-124.
Eerola I, Boon LM, Mulliken JB, Aylett A, Dompmartin A, Lemaire A, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73(6):1240-1249.
Wouters V, Limaye N, Uebelhoer M, Ghosh S, Kim D, D’Amore PA, et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet. 2010;18(4):414-420.
Brouillard P, Boon LM, Revencu N, McCuaig C, Vikkula M, Pannett A, et al. Genotypes and phenotypes of 162 families with a glomulin mutation. Mol Syndromol. 2013;4(4):157-164.
Soblet J, Kangas J, Nätynki M, Järvinen P, Eerola I, Vikkula M, et al. Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations. J Invest Dermatol. 2017;137(1):207-216.
Seront E, Boon LM, Vikkula M. TEK-Related Venous Malformations. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1967/. Last updated Mar 2, 2023; cited Oct 16, 2024.
Heit JJ, Do HM, Prestigiacomo CJ, McCuaig C, Wu Y, Kuo A, et al. Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations. J Neurointerv Surg. 2017;9(6):611-617.
Tieu DD, Ghodke B V, Vo NJ, Perkins JA. Single-stage excision of localized head and neck venous malformations using preoperative glue embolization. Otolaryngol Head Neck Surg. 2013;148(4):678-684.
Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010;125(4):1185-1194.
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476-483.
Al-Olabi L, Polubothu S, Dowsett K, Kwan H, Larkin J, Lee D, et al. Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest. 2018;128(4):1496-1508.
Nikolaev SI, Vetiska S, Bonilla X, Pannett A, Tsang R, Smith A, et al. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain. N Engl J Med. 2018;378(3):250-261.
Couto JA, Huang AY, Konczyk DJ, DiGuglielmo C, Chang K, Wang C, et al. Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation. Am J Hum Genet. 2017;100(3):546-554.
Revencu N, Boon LM, Mendola A, MacKenzie R, Ghosh S, Vikkula M, et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat. 2013;34(12):1632-1641.
Parambil JG. Hereditary Hemorrhagic Telangiectasia. Clin Chest Med. 2016;37(3):513-521.
Lekwuttikarn R, Lim YH, Admani S, Choate KA, Teng JMC. Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child. JAMA Dermatol. 2019;155(2):256-257.
Hashimoto T, Matsumoto MM, Li JF, Lawton MT, Young WL, University of California SFBSG. Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol. 2005;5(1):1.
Elsenousi A, Aletich VA, Alaraj A. Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis. J Neurointerv Surg. 2016;8(3):265-272.
Kim JY, Kim DI, Do YS, Lee DY, Kim JH, Cho YP, et al. Surgical treatment for congenital arteriovenous malformation: 10 years’ experience. Eur J Vasc Endovasc Surg. 2006;32(1):101-106.
Cox JA, Bartlett E, Lee EI. Vascular malformations: a review. Semin Plast Surg. 2014;28(2):58-63.
Ng AT, Tower RL, Drolet BA. Targeted treatment of vascular anomalies. Int J Womens Dermatol. 2021;7(5Part A):636-639.
Horii KA, Drolet BA, Frieden IJ, Munden A, Blei F, McCuaig C, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol. 2011;28(3):245-253.
Metry DW, Haggstrom AN, Drolet BA, Frieden IJ, Lammer EJ, Schaffer R, et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A. 2006;140(9):975-986.
Garzon MC, Epstein LG, Heyer GL, Grieden IJ, Haggstrom AN, Drolet BA, et al. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr. 2016;178:24-33.e2.
Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr. 1997;131(4):643-646.
Weber FC, Greene AK, Adams DM, Blei F, Drolet BA, Leach JL, et al. Role of imaging in the diagnosis of parotid infantile hemangiomas. Int J Pediatr Otorhinolaryngol. 2017;102:61-66.
Bly RA, Holdefer RN, Slimp J, Kelly S, Craig J, Stal S, et al. Preoperative Facial Nerve Mapping to Plan and Guide Pediatric Facial Vascular Anomaly Resection. JAMA Otolaryngol Head Neck Surg. 2018;144(5):418-426.
Downloads
Published
How to Cite
License
Copyright (c) 2024 Caleb Allred, Kaitlyn Zenner, Juliana Bonilla-Velez
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org
